Use of Armodafinil for Fatigue in Sarcoidosis

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Sarcoidosis, Fatigue, Sleepiness

In brief

To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.

Key facts

Study ID

NCT00555347

Run by

University of Cincinnati

People needed

20

Starts

2007-10-01

Expected to finish

2011-08-01

Last updated by the study team

2015-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of sarcoidosis using standard criteria 15.
• Disease for more than one year
• On stable, systemic therapy
• Complain of fatigue which has been present for more than six months.
• Over 18 years of age
• Provide written informed consent.

You may not qualify if…

• Pregnancy
• Change in therapy for sarcoidosis in prior three months
• History of ventricular arrythmias

Where it is running

• University of Cincinnati — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.